
Fredun Pharmaceuticals Share Price
₹675.40 -4.1 (-0.6%)
12 Mar, 2025 07:14
Start SIP in
FREDUN
Performance
- Low
- ₹0
- High
- ₹0
- 52 Week Low
- ₹0
- 52 Week High
- ₹0
- Open Price₹0
- Previous Close₹0
- Volume
Investment Returns
- Over 1 Month -7.02%
- Over 3 Month -7.17%
- Over 6 Month -14.51%
- Over 1 Year -16.37%
Smart Investing Starts Here Start SIP with Fredun Pharmaceuticals for Steady Growth!
Fredun Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
Fredun Pharmaceuticals Financials
Fredun Pharmaceuticals Technicals
EMA & SMA
Current Price
₹675.40
-4.1
(-0.6%)

-
- Bearish Moving Average 14
-
- Bullish Moving Average 2
- 20 Day
- ₹683.76
- 50 Day
- ₹696.99
- 100 Day
- ₹717.10
- 200 Day
- ₹752.24
Resistance and Support
671.13
- R3 701.42
- R2 690.43
- R1 682.12
- S1 662.82
- S2 651.83
- S3 643.52
Fredun Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-02-04 | Quarterly Results | |
2024-10-26 | Quarterly Results | |
2024-10-03 | Others | inter alia consider issue and allotment of Unsecured Foreign Currency ConvertibleBonds (FCCBs), in accordance with the provisions of the SEBI Regulations, 2018 and the Companies Act, 2013. alia, to consider a proposal for fund raising up to Rs.120 crores by way of further public offer, rights issue, debt issue, preferential issue or any other method. |
2024-07-29 | Quarterly Results | |
2024-05-07 | Audited Results & Final Dividend |
Fredun Pharmaceuticals F&O
About Fredun Pharmaceuticals
- NSE Symbol
- FREDUN
- BSE Symbol
- 539730
- Managing Director & CFO
- Mr. Fredun Medhora
- ISIN
- INE194R01017
Similar Stocks to Fredun Pharmaceuticals
Fredun Pharmaceuticals FAQs
Fredun Pharmaceuticals share price is ₹675 As on 12 March, 2025 | 07:00
The Market Cap of Fredun Pharmaceuticals is ₹318.9 Cr As on 12 March, 2025 | 07:00
The P/E ratio of Fredun Pharmaceuticals is 17 As on 12 March, 2025 | 07:00
The PB ratio of Fredun Pharmaceuticals is 2.4 As on 12 March, 2025 | 07:00
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.